Jump to content

20250213645. Pharmaceutical Composition Fo (L-BASE ., .)

From WikiPatents

PHARMACEUTICAL COMPOSITION FOR MODULATING IMMUNE RESPONSE

Abstract: the present invention relates to a pharmaceutical composition for enhancing immunity, and was arrived at by discovering that oligopeptide aqtgtgkt and an analog thereof have the effect of approximately modulating immune activity in the body, such as by suppressing excessive immune response while enhancing immune activity for defending the body from cancer or infectious diseases and the like. in particular, the compound according to the present invention can significantly improve the sensitivity of a subject to an immune anticancer drug, activate immune cells in a tumor microenvironment through the regulation of cytokines, chemokines, etc., and inhibit excessive autophagy activity to control physiological balance, and thus using the compound in combination with immune anti-cancer drugs can maximize the anticancer effect thereof. therefore, the compound according to the present invention can optimize the body's defense function and enhance the effect of immune anticancer drugs and the like through the control of immune response, and thus is expected to be utilized in the treatment of various immune diseases and cancer.

Inventor(s): Do Yong JEON

CPC Classification: A61K38/08 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250213645


Cookies help us deliver our services. By using our services, you agree to our use of cookies.